ENO1 and cancer: The demonstration that SA and amoB1 bind and inhibit ENO1 and PKM2 in vitro, and that SA reduces the rate of aerobic glycolysis in HEK293 cells provides potentially useful insights into the anti-inflammatory and/or anti-cancer activities of salicylates.